ZMYND10 could serve as a prognostic biomarker for patients with prostate cancer

Asian J Surg. 2023 Nov;46(11):5376-5378. doi: 10.1016/j.asjsur.2023.07.093. Epub 2023 Sep 5.

¹ Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; West China School of medicine, West China Hospital, Sichuan University, China.
² Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
³ Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China. Electronic address: [email protected].

No abstract available

Publication types